Exploring regulatory mechanisms of glyoxalase-1
Exploring regulatory mechanisms of glyoxalase-1
批准号:
10646721
负责人:
JACOB M HAUS
金额:
$23.4万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-15 至 2025-02-28
关键词:
AccelerationAcetylationAdultAdvanced Glycosylation End ProductsAgingAlanineAmino AcidsAntioxidantsAttenuatedCRISPR/Cas technologyCarbonCell Culture TechniquesCell LineCell physiologyCellsClustered Regularly Interspaced Short Palindromic RepeatsCoupledDataDeacetylaseDeacetylationDiseaseDrug Metabolic DetoxicationEnzymesGene DosageGenerationsGenesGlucose IntoleranceHealthHeterozygoteHumanImpairmentInflammationInflammatoryInsulin ResistanceKnock-outKnowledgeLactoylglutathione LyaseLongevityLysineMeasuresMediatingMetabolicMetabolic DiseasesMetabolismMitochondriaModelingModificationMuscleMuscle FibersMuscle functionMutagenesisMutateNADHNon-Insulin-Dependent Diabetes MellitusNucleotidesObesityOrganOvernutritionOxidative StressPeptidesPhenotypePhosphorylationPhosphorylation InhibitionPhysiologicalPolyubiquitinationPost-Translational Modification SitePost-Translational Protein ProcessingProcessProductionProteinsProteomicsPyruvaldehydeReactive Oxygen SpeciesRegulationRoleSIRT1 geneSirtuinsSkeletal MuscleStressSystemTechnologyThinnessThreonineTissuesWorkadductadult obesityage relatedattenuationfunctional outcomesgain of functiongenome editingglucose metabolismglycationhealthspanin silicoin vitro Modelinhibitorknock-downloss of functionmutantnicotinamide phosphoribosyltransferasenicotinamide-beta-ribosidenovelobesogenicpreservationsenescenceskeletal muscle metabolismstressortargeted treatmenttherapeutic targettranslational modelyoung adult
中文摘要
项目摘要
甲基乙二醛(MG)是一种有效的细胞内糖化剂,可形成晚期糖基化终产物。形成
自发地从3-碳糖酵解中间体,MG迅速地使蛋白质和核苷酸变性,
线粒体,并直接增加活性氧的产生;从而诱导促氧化状态,
类似衰老的状况MG和相关的glycoprotein酶的酶防御系统正在成为关键
参与衰老和与年龄相关的疾病过程。在生理条件下,MG通过以下途径迅速解毒:
glycoproteinase 1(GLO1)。然而,当GLO 1减弱时,MG通量增加,MG修饰的蛋白质,
积累(称为二羰基应激),在细胞内外。二羰基应激促进葡萄糖
不耐受、氧化应激和炎症。调节GLO 1蛋白稳定性和酶促作用的机制
骨骼肌组织是葡萄糖代谢的关键组织,其活性尚未得到很好的研究,
需要了解GLO 1减少在肥胖、衰老和年龄背景下的功能后果-
相关疾病。GLO 1对细胞功能至关重要,并受到许多翻译后修饰
(PTMs)调节GLO 1蛋白的稳定性和活性。我们的目标是建立稳健的翻译模型
描述GLO 1的调节机制,以更好地了解GLO 1的功能后果。
减毒GLO 1。新的、最先进的翻译模型的产生将有助于加速
了解GLO 1衰减和二羰基应激以及对骨骼肌健康的影响,
寿命和健康寿命。我们的目标是建立GLO 1缺失和细胞凋亡的功能相关性。
人肌管中GLO 1的PTM的影响。我们的方法是减弱GLO 1并突变关键氨基酸
使用CRISPR基因编辑技术,结合二羰基应激措施,我们期望
鉴定GLO 1失调和甲基甘氨酸介导损伤的新的肌肉特异性机制。的
这项工作的顺利完成将对促进谅解产生重要的积极影响,
提供潜在的治疗靶点,以维持骨骼肌功能与衰老和年龄相关疾病。
英文摘要
PROJECT ABSTRACT
Methylglyoxal (MG) is a potent intracellular glycating agent that forms advanced glycation endproducts. Formed
spontaneously from 3-carbon glycolytic intermediates, MG rapidly glycates proteins and nucleotides, damages
mitochondria and directly increases reactive oxygen species production; thus inducing a pro-oxidant state and
senescent-like condition. MG and the related glyoxalase enzymatic defense system are emerging as critical
players in aging and age-related disease processes. Under physiologic conditions MG is rapidly detoxified by
glyoxalase 1 (GLO1). However, when GLO1 is attenuated, MG flux is increased and MG-modified proteins
accumulate (termed dicarbonyl stress), both within and outside the cell. Dicarbonyl stress promotes glucose
intolerance, oxidative stress and inflammation. The mechanisms regulating GLO1 protein stability and enzymatic
activity in skeletal muscle tissue, a tissue critical to glucose metabolism, are not well studied and there is a critical
need to understand the functional consequences of reduced GLO1 in the context of obesity, aging and age-
related disease. GLO1 is critical to cellular function and subject to numerous posttranslational modifications
(PTMs) that regulate GLO1 protein stability and activity. Our objective is to establish robust translational models
to delineate the mechanisms by which GLO1 is regulated to better understand the functional consequences of
attenuated GLO1. The generation of new, state-of-the-art translational models will help to accelerate the
understanding of GLO1 attenuation and dicarbonyl stress and the implications for skeletal muscle health across
both the life-span and health-span. We aim to establish the functional relevance of both GLO1 loss and the
impact of PTMs of GLO1 in human myotubes. Our approach is to attenuate GLO1 and mutate critical amino acid
residues using CRISPR gene editing technology, coupled with measures of dicarbonyl stress. We expect to
identify a novel, muscle specific mechanism of GLO1 dysregulation and methylglyoxal-mediated damage. The
successful completion of this work will have an important positive impact on advancing the understanding, and
provide potential therapeutic targets, to maintain skeletal muscle function with aging and age-related disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Strategies and functional outcomes of enhancing in vivo production of soluble rage isoforms
-
批准号:9505899
-
项目类别:
-
资助金额:$60.16万
-
财政年份:2016
-
负责人:JACOB M HAUS
-
依托单位:
海外基金